rs121908088
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The ENST00000329066.9(TPO):āc.1978C>Gā(p.Gln660Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,614,164 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Genomes: š 0.00018 ( 0 hom., cov: 33)
Exomes š: 0.00033 ( 1 hom. )
Consequence
TPO
ENST00000329066.9 missense
ENST00000329066.9 missense
Scores
8
9
2
Clinical Significance
Conservation
PhyloP100: 7.24
Genes affected
TPO (HGNC:12015): (thyroid peroxidase) This gene encodes a membrane-bound glycoprotein. The encoded protein acts as an enzyme and plays a central role in thyroid gland function. The protein functions in the iodination of tyrosine residues in thyroglobulin and phenoxy-ester formation between pairs of iodinated tyrosines to generate the thyroid hormones, thyroxine and triiodothyronine. Mutations in this gene are associated with several disorders of thyroid hormonogenesis, including congenital hypothyroidism, congenital goiter, and thyroid hormone organification defect IIA. Multiple transcript variants encoding distinct isoforms have been identified for this gene, but the full-length nature of some variants has not been determined. [provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-1494011-C-G is Pathogenic according to our data. Variant chr2-1494011-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 4053.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.25727427). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPO | NM_001206744.2 | c.1978C>G | p.Gln660Glu | missense_variant | 11/17 | ENST00000329066.9 | NP_001193673.1 | |
LOC124905966 | XR_007086185.1 | n.167-7820G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPO | ENST00000329066.9 | c.1978C>G | p.Gln660Glu | missense_variant | 11/17 | 1 | NM_001206744.2 | ENSP00000329869 | P1 | |
ENST00000650512.1 | n.548-75550G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152198Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
28
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000323 AC: 81AN: 251150Hom.: 1 AF XY: 0.000287 AC XY: 39AN XY: 135796
GnomAD3 exomes
AF:
AC:
81
AN:
251150
Hom.:
AF XY:
AC XY:
39
AN XY:
135796
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000327 AC: 478AN: 1461848Hom.: 1 Cov.: 33 AF XY: 0.000287 AC XY: 209AN XY: 727216
GnomAD4 exome
AF:
AC:
478
AN:
1461848
Hom.:
Cov.:
33
AF XY:
AC XY:
209
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74468
GnomAD4 genome
AF:
AC:
28
AN:
152316
Hom.:
Cov.:
33
AF XY:
AC XY:
13
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
42
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Deficiency of iodide peroxidase Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2008 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Oct 19, 2020 | Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0200 - Variant is predicted to result in a missense amino acid change from glutamine to glutamic acid (exon 11). (N) 0251 - Variant is heterozygous. (N) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (84 heterozygotes, 1 homozygote). (P) 0502 - Missense variant with conflicting in silico predictions and/or uninformative conservation. (N) 0600 - Variant is located in an annotated domain or motif (An_peroxidase domain; PDB, DECIPHER, NCBI). (N) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0801 - Strong previous evidence of pathogenicity in unrelated individuals. This variant has been identified in several patients with both non-toxic and toxic goiter and congenital hypothyroidism as homozygotes and compound heterzoygotes (ClinVar; PMID: 18029453, 15745925, 10468986) (P) 0901 - Strong evidence for segregation with disease. This variant has been shown to segregate in 5 families (PMID: 18029453, 15745925, 10468986). (P) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 07, 2019 | The TPO c.1978C>G (p.Gln660Glu) missense variant has been reported in at least four studies in which it is found in a total of 25 individuals affected with congenital hypothyroidism from 17 families, including in one in a homozygous state, in 14 in a compound heterozygous state and in 10 with unknown zygosity (Santos et al. 1999; Rodrigues et al. 2005; Deladoey et al. 2008; Al-Faisal et al. 2014). The p.Gln660Glu variant was absent from 75 controls and is reported at a frequency of 0.003326 in the Other population of the Exome Aggregation Consortium. The Gln660 residue is noted to be well conserved. Immunohistochemistry of the thyroid from an affected patient carrying the p.Gln660Glu variant with an anti-TPO antibody revealed a pattern similar to the normal control. However, the substitution of the glutamine residue by a glutamate severely affects the electrostatic potential of the residue generating an altered electrostatic environment around its catalytic site (Deladoey et al. 2008). Based on the collective data, the p.Gln660Glu variant is classified as pathogenic for congenital hypothyroidism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 660 of the TPO protein (p.Gln660Glu). This variant is present in population databases (rs121908088, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of thyroid dyshormonogenesis (PMID: 10468986, 15745925, 18029453, 24482635, 31430255). It has also been observed to segregate with disease in related individuals. This variant is also known as C to G at position 2068. ClinVar contains an entry for this variant (Variation ID: 4053). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TPO protein function. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 05, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28648508, 10468986, 18029453, 24482635, 25968604, 31589614, 31301652, 35995307, 34200080, 31430255, 34211162, 15745925, 34220711, 34248839, 35272499, Jeong2020[paper], 35507000) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;H;.;H;.;.;.
MutationTaster
Benign
A;A;A;A;A;A;A
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D
Polyphen
D;D;D;D;D;.;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at